(Reuters) – European stock index futures surged more than 3% on Friday, as U.S. President Donald Trump rolled out plans for a gradual re-opening of the economy and on reports of a potential drug to treat the COVID-19 disease.
Euro Stoxx 50 futures () were up 3.3% at 0600 GMT, with German (), French () and () futures jumping between 2.8% and 3.4%, shrugging off data showing China suffered its worst economic contraction in almost three decades.
The benchmark STOXX 600 index () has rallied about 20% since hitting an eight-year low in March on the back of historic global stimulus and on hopes strict stay-at-home orders would be eased as the health crisis showed signs of ebbing.
Late on Thursday, Trump laid out new guidelines for U.S. states to emerge from the shutdowns in a staggered, three-stage approach, sending S&P 500 futures
Also lifting the mood at the end of the week, a report detailed encouraging partial data from trials of U.S. drugmaker Gilead Sciences Inc (NASDAQ:)’s experimental drug remdesivir in severe COVID-19 patients.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment